Kerstin Mock
University of Freiburg(DE)University Medical Center Freiburg(DE)Immatics Biotechnologies (Germany)(DE)
Publications by Year
Research Areas
Cancer Cells and Metastasis, Proteoglycans and glycosaminoglycans research, Hippo pathway signaling and YAP/TAZ, Peptidase Inhibition and Analysis, Immunotherapy and Immune Responses
Most-Cited Works
- → ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types(2016)296 cited
- → ZEB 1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat(2015)229 cited
- → A self‐enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells(2015)189 cited
- → Zeb1 Regulates E-cadherin and Epcam (Epithelial Cell Adhesion Molecule) Expression to Control Cell Behavior in Early Zebrafish Development(2013)89 cited
- → A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer(2017)69 cited
- → The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors(2015)62 cited
- → Abstract 3753: Identification of antibodies against a novel tumor-associated MHC/peptide-target and generation of highly specific and potent HLA-A*02MMP1-003/CD3 TandAbs(2017)1 cited